Clinical Trial Update: Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study [NA]

View source ↗

Summary

The SupCare study evaluating simultaneous care in recurrent and/or metastatic head and neck cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Head and Neck Neoplasms | NA | Status: WITHDRAWN